<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:44:16Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:3349548" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:3349548</identifier><datestamp>2012-05-11</datestamp><setSpec>bmcbiology</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Biol</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Biol</journal-id>
      <journal-title-group>
        <journal-title>BMC Biology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1741-7007</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC3349548</article-id>
      <article-id pub-id-type="pmcid">PMC3349548</article-id>
      <article-id pub-id-type="pmc-uid">3349548</article-id>
      <article-id pub-id-type="pmid">22537386</article-id>
      <article-id pub-id-type="publisher-id">1741-7007-10-36</article-id>
      <article-id pub-id-type="pmid">22537386</article-id>
      <article-id pub-id-type="doi">10.1186/1741-7007-10-36</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>UBXN7 docks on neddylated cullin complexes using its UIM motif and causes HIF1Î± accumulation</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" id="A1">
          <name>
            <surname>Bandau</surname>
            <given-names>Susanne</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>s.bandau@dundee.ac.uk</email>
        </contrib>
        <contrib contrib-type="author" id="A2">
          <name>
            <surname>Knebel</surname>
            <given-names>Axel</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>a.knebel@dundee.ac.uk</email>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>Gage</surname>
            <given-names>Zoe O</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>zoe.gage@lshtm.ac.uk</email>
        </contrib>
        <contrib contrib-type="author" id="A4">
          <name>
            <surname>Wood</surname>
            <given-names>Nicola T</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>n.wood@dundee.ac.uk</email>
        </contrib>
        <contrib contrib-type="author" corresp="yes" id="A5">
          <name>
            <surname>Alexandru</surname>
            <given-names>Gabriela</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>g.alexandru@dundee.ac.uk</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Scottish Institute for Cell Signalling (SCILLS), College of Life Sciences, University of Dundee, Dow St, Dundee DD1 5EH, UK</aff>
      <aff id="I2"><label>2</label>London School of Hygiene and Tropical Medicine, Keppel St, London WC1E 7HT, UK</aff>
      <pub-date pub-type="collection">
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>26</day>
        <month>4</month>
        <year>2012</year>
      </pub-date>
      <volume>10</volume>
      <fpage>36</fpage>
      <lpage>36</lpage>
      <history>
        <date date-type="received">
          <day>30</day>
          <month>3</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>26</day>
          <month>4</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright Â©2012 Bandau et al; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2012</copyright-year>
        <copyright-holder>Bandau et al; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.biomedcentral.com/1741-7007/10/36"/>
      <abstract>
        <sec>
          <title>Background</title>
          <p>The proteins from the UBA-UBX family interact with ubiquitylated proteins via their UBA domain and with p97 via their UBX domain, thereby acting as substrate-binding adaptors for the p97 ATPase. In particular, human UBXN7 (also known as UBXD7) mediates p97 interaction with the transcription factor HIF1Î± that is actively ubiquitylated in normoxic cells by a CUL2-based E3 ligase, CRL2. Mass spectrometry analysis of UBA-UBX protein immunoprecipitates showed that they interact with a multitude of E3 ubiquitin-ligases. Conspicuously, UBXN7 was most proficient in interacting with cullin-RING ligase subunits. We therefore set out to determine whether UBXN7 interaction with cullins was direct or mediated by its ubiquitylated targets bound to the UBA domain.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>We show that UBXN7 interaction with cullins is independent of ubiquitin- and substrate-binding. Instead, it relies on the UIM motif in UBXN7 that directly engages the NEDD8 modification on cullins. To understand the functional consequences of UBXN7 interaction with neddylated cullins, we focused on HIF1Î±, a CUL2 substrate that uses UBXD7/p97 as a ubiquitin-receptor on its way to proteasome-mediated degradation. We find that UBXN7 over-expression converts CUL2 to its neddylated form and causes the accumulation of non-ubiquitylated HIF1Î±. Both of these effects are strictly UIM-dependent and occur only when UBXN7 contains an intact UIM motif. We also show that HIF1Î± carrying long ubiquitin-chains can recruit alternative ubiquitin-receptors, lacking p97's ATP-dependent segregase activity.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Our study shows that independently of its function as a ubiquitin-binding adaptor for p97, UBXN7 directly interacts with neddylated cullins and causes the accumulation of the CUL2 substrate HIF1Î±. We propose that by sequestering CUL2 in its neddylated form, UBXN7 negatively regulates the ubiquitin-ligase activity of CRL2 and this might prevent recruitment of ubiquitin-receptors other than p97 to nuclear HIF1Î±.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>cullin</kwd>
        <kwd>NEDD8</kwd>
        <kwd>p97</kwd>
        <kwd>ubiquitin-dependent degradation</kwd>
        <kwd>UBXD7</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Proteins destined for proteasome-mediated degradation are labeled with ubiquitin chains through the action of an enzymatic cascade consisting of a ubiquitin-activating enzyme (E1), a ubiquitin-conjugating enzyme (E2), and a ubiquitin-ligase (E3) [<xref ref-type="bibr" rid="B1">1</xref>]. Downstream of ubiquitylation, ubiquitin-receptors recognize the poly-ubiquitylated proteins and facilitate their degradation by the proteasome [<xref ref-type="bibr" rid="B2">2</xref>]. Some ubiquitin-receptors, such as PSMD4 (known as Rpn10 in yeast) and RPN13, are intrinsic to the regulatory particle of the proteasome [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>]. Others, such as those from the RAD23 or ubiquilin families, shuttle on and off the proteasome [<xref ref-type="bibr" rid="B5">5</xref>]. In addition to the single subunit receptors mentioned above, a distinct class of ubiquitin-receptors endowed with ATPase activity has at its core p97 hexamers. It has been proposed that p97 functions as a 'segregase' by converting the ATP-derived energy into mechanical force [<xref ref-type="bibr" rid="B6">6</xref>-<xref ref-type="bibr" rid="B8">8</xref>]. Indeed, p97 complexes can separate their substrates from cellular structures, such as the endoplasmic-reticulum membrane [<xref ref-type="bibr" rid="B9">9</xref>], or from protein partners [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B10">10</xref>]. The p97 protein itself has little affinity for ubiquitin and relies on its interaction with ubiquitin-binding adaptors to function as a ubiquitin-receptor. Such adaptors include the NPL4/UFD1 dimer [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>] and the UBA-UBX proteins [<xref ref-type="bibr" rid="B13">13</xref>]. The latter employ their UBX domain to interact with the N-terminus of p97 and the UBA (ubiquitin-associated) domain to bind ubiquitylated proteins [<xref ref-type="bibr" rid="B14">14</xref>]. Humans express five UBA-UBX proteins: UBXN7, FAF1, FAF2, UBXN1, and p47. A striking observation from the mass spectrometry analysis of UBA-UBX protein immunoprecipitates is their ability to interact with a large number of E3 ubiquitin-ligases [<xref ref-type="bibr" rid="B15">15</xref>]. These include components of cullin-RING E3 ligase (CRL) complexes and also single subunit RING- and HECT-domain E3s.</p>
      <p>Similar to ubiquitin, the ubiquitin-like (UBL) protein NEDD8 is attached to its substrates by specific E1, E2 and E3 enzymes. To date, cullins represent the major class of proteins that are targets for neddylation [<xref ref-type="bibr" rid="B16">16</xref>]. The NEDD8 E3 activity in this case is provided by the dual action of DCN1 [<xref ref-type="bibr" rid="B17">17</xref>-<xref ref-type="bibr" rid="B19">19</xref>] and the RING subunit of the CRL complex [<xref ref-type="bibr" rid="B20">20</xref>-<xref ref-type="bibr" rid="B22">22</xref>]. It has been known for over a decade that cullin-neddylation is essential for the E3 activity of CRL complexes [<xref ref-type="bibr" rid="B23">23</xref>]. Recent structural and biochemical studies elucidated the complex molecular mechanism underlying CRL activation by the NEDD8 modification. Neddylation induces a major conformational change in the cullin that essentially allows the RING domain of RBX1 to spring free from the cullin. It is this increased flexibility of the RING-domain that ultimately translates into superior ubiquitin-ligase activity of CRLs [<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B25">25</xref>].</p>
      <p>We have previously identified HIF1Î± as a novel substrate of p97, with the UBA-UBX protein UBXN7 serving as the substrate-binding adaptor [<xref ref-type="bibr" rid="B15">15</xref>]. HIF1Î± heterodimerizes with HIF1Î² to form the HIF1 transcription factor that is essential during hypoxia for triggering the expression of specific proteins required to counteract the hypoxic stress [<xref ref-type="bibr" rid="B26">26</xref>]. HIF1Î± is continuously expressed during normoxia and is actively targeted for ubiquitin-mediated degradation through the action of a CUL2-based CRL complex (CRL2). Within CRL2, CUL2 acts as a scaffold to which the RING subunit (RBX1) and the elongin B/elongin C dimer bind. VHL docks on elongin C and directly interacts with HIF1Î± [<xref ref-type="bibr" rid="B27">27</xref>], acting as a substrate-binding adaptor for the CRL2 complex (Figure <xref ref-type="fig" rid="F1">1A</xref>). Consistent with p97 having a positive role in HIF1Î± degradation, HIF1Î± accumulates upon p97 depletion by siRNA. Paradoxically, UBXN7 depletion results in reduced levels of HIF1Î±, indicating that UBXN7 involvement in HIF1Î± degradation is more complex than anticipated [<xref ref-type="bibr" rid="B15">15</xref>].</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p><bold>Ubiquitin- and substrate-binding to UBXN7 do not correlate with CUL2 binding</bold>. (<bold>A</bold>) Illustration of the CRL2 ubiquitin-ligase bound to its substrate HIF1Î±. The core subunits of CRL2 are highlighted in blue. The UBA-UBX protein UBXN7 interacts with ubiquitylated HIF1Î± via its UBA domain. (<bold>B</bold>) CUL2 interaction with UBXN7 is independent of ubiquitin-binding. Flag-UBXN7 was immunoprecipitated from cells thermo-sensitive for the ubiquitin-E1. When these cells were grown at the restrictive temperature for 20 hours, there was a marked reduction in protein ubiquitylation (right panel). CUL2-binding to UBXN7 was not affected by the reduced ubiquitin-binding observed under these conditions (left panel). (<bold>C</bold>) Flag-UBXN7 stably interacts with the core subunits of the CRL2 complex. Flag-UBXN7 was immunoprecipitated from HeLa cells treated or not with 10 Î¼M MG132 for two hours. Flag-UBXN7 stably interacted with CUL2, elongin C and RBX1. The interaction with HIF1Î± and VHL could only be detected upon proteasome inhibition (left panel). (<bold>D</bold>) Endogenous UBXN7 stably interacts with the core subunits of the CRL2 complex. As in (C), but endogenous UBXN7 was immunoprecipitated from HeLa cells using specific antibodies crosslinked to protein A-beads. (<bold>B</bold>-<bold>D</bold>) The indicated proteins were detected using specific antibodies in the immunoprecipitates (left) and the input cell extracts (right).</p>
        </caption>
        <graphic xlink:href="1741-7007-10-36-1"/>
      </fig>
      <p>Here we show that UBXN7 interaction with cullins is not mediated by its ubiquitylated substrates, but involves the direct docking of the UIM motif in UBXN7 onto the neddylated cullins. UBXN7 over-expression causes non-ubiquitylated HIF1Î± to accumulate in a manner that is dependent on an intact UIM motif in UBXD7. Our data suggest that UBXN7 may act as a negative regulator of CRL2 and this would favor subsequent recruitment of p97.</p>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <sec>
        <title>Active ubiquitylation is not necessary for UBXN7 interaction with CUL2</title>
        <p>Among human UBA-UBX proteins, UBXN7 is the most proficient in interacting with CRL subunits. Indeed, its ability to interact with CUL2 greatly outshines other UBA-UBX proteins [<xref ref-type="bibr" rid="B15">15</xref>]. We therefore set out to further explore UBXN7 interaction with CRL2. Our initial assumption was that the interaction of UBA-UBX proteins with E3 ubiquitin-ligases was indirect, mediated by their ubiquitylated substrates. To test this hypothesis we used the A31N-ts20 cells, which are mouse embryo fibroblasts thermosensitive for the ubiquitin-E1 [<xref ref-type="bibr" rid="B28">28</xref>]. When these cells are grown at the non-permissive temperature, the initial step in the protein-ubiquitylation cascade is blocked leading to a dramatic reduction in the levels of ubiquitylated proteins compared to control cells grown at 35Â°C (Figure <xref ref-type="fig" rid="F1">1B</xref>). As an added proof that the ubiquitylation pathway was defective, we observed HIF1Î± accumulation in the cells grown at 39Â°C. Although ubiquitin-binding to Flag-UBXN7 was drastically reduced, UBXN7 interaction with CUL2 was unaffected (Figure <xref ref-type="fig" rid="F1">1B</xref>).</p>
      </sec>
      <sec>
        <title>UBXN7 stably interacts with the core CRL2 complex</title>
        <p>Next we examined UBXN7 interaction with other components of the CRL2 complex. Flag-UBXN7 effectively co-immunoprecipitated CUL2, elongin C and RBX1, which constitute the core CRL2 complex. In contrast, UBXN7 interaction with VHL and HIF1Î± could only be observed upon brief inhibition of the proteasome with MG132 (Figure <xref ref-type="fig" rid="F1">1C</xref>). Similar results were obtained when endogenous UBXN7 was immunoprecipitated using specific antibodies (Figure <xref ref-type="fig" rid="F1">1D</xref>).</p>
        <p>The data presented thus far indicated that UBXN7 binding to CUL2 was not mediated by its interaction with ubiquitylated-proteins that are CRL2 substrates. This raised the interesting hypothesis that UBXN7 might interact directly with the CRL2 core complex, irrespective of whether it is charged with a substrate (Figure <xref ref-type="fig" rid="F1">1A</xref>).</p>
      </sec>
      <sec>
        <title>Cullin-neddylation is required for the interaction with UBXN7</title>
        <p>We observed that UBXN7 interacted preferentially with the neddylated form of CUL2, which was largely depleted from the extracts after Flag-UBXN7 immunoprecipitation (Figure <xref ref-type="fig" rid="F2">2A</xref>, compare lanes 3 and 4). We also noticed that Flag-UBXN7 over-expression causes an up-shift of CUL2 to a slower migrating form (Figure <xref ref-type="fig" rid="F2">2B</xref>). To confirm that this is indeed neddylated-CUL2, we used a chemical inhibitor of the NEDD8-E1, MLN4924 [<xref ref-type="bibr" rid="B29">29</xref>]. MLN4924 abolished cullin-neddylation and also the CUL2 up-shift caused by UBXN7 over-expression (Figure <xref ref-type="fig" rid="F2">2B</xref>). To investigate the possibility that cullin-neddylation is required for the interaction with UBXN7, we created two neddylation-defective CUL2 mutants, K689R and K719R. Lys689 is the site of NEDD8-conjugation in human CUL2 and mutating this residue to arginine abolishes neddylation [<xref ref-type="bibr" rid="B30">30</xref>]. Lys719 is a conserved residue among cullins and its equivalent in yeast Cdc53 is part of the interaction surface with Dcn1 [<xref ref-type="bibr" rid="B17">17</xref>] (Figure <xref ref-type="fig" rid="F2">2C</xref>). CUL2-neddylation was largely defective in the K719R mutant (Figure <xref ref-type="fig" rid="F2">2D</xref>), presumably due to its inability to interact with the DCN1 component of the NEDD8-E3. We attempted to test whether this mutant was defective in binding the human DCN1-like protein, but DCNL1 was undetectable even in wild-type Flag-CUL2 immunoprecipitates. None of the above mutations affected CUL2 interaction with RBX1 (Figure <xref ref-type="fig" rid="F2">2D</xref>). Strikingly, there was a precise correlation between CUL2-neddylation and its ability to interact with endogenous UBXN7. UBXN7 binding was completely abolished in the K689R mutant and strongly reduced in the K719R mutant (Figure <xref ref-type="fig" rid="F2">2D</xref>). Thus, neddylation was required for CUL2 interaction with UBXN7. This is a common feature among cullins, because MLN4924 treatment prevented not only UBXN7 interaction with CUL2, but also with CUL1, CUL3 and CUL4A (Figure <xref ref-type="fig" rid="F2">2E</xref>). The defect in cullin-binding caused by MLN4924 treatment could not be rescued by simultaneous treatment with the proteasome inhibitor MG132 (Figure <xref ref-type="fig" rid="F2">2E</xref>). In contrast, MLN4924 treatment did not affect UBXN7 interaction with ubiquitylated-proteins or with p97 (Figure <xref ref-type="fig" rid="F2">2F</xref>).</p>
        <fig id="F2" position="float">
          <label>Figure 2</label>
          <caption>
            <p><bold>UBXN7 exclusively interacts with neddylated cullins in cell extracts</bold>. (<bold>A</bold>) UBXN7 preferentially interacts with slower-migrating, neddylated CUL2. Input cell extracts and the supernatants after Flag-UBXN7 immunoprecipitation were compared. (<bold>B</bold>) Flag-UBXN7 over-expression causes an up-shift of CUL2 to its neddylated form. This effect was abolished when the cells were grown in the presence of the NEDD8-E1 inhibitor MLN4924 for two hours. (<bold>C</bold>) Alignment of human CUL2 with the yeast cullin Cdc53. The conserved neddylation site (K689) and a more C-terminal Lys residue involved in the interaction with Dcn1 (K719) are highlighted in red. (<bold>D</bold>) Neddylation-defective CUL2 variants are similarly defective in interacting with endogenous UBXN7. Wild-type or mutant Flag-CUL2 was immunoprecipitated from HeLa cells treated or not with 10 Î¼M MG132 for two hours. (<bold>E</bold>) MLN4924 treatment abolishes UBXN7 interaction with several endogenous cullins. (<bold>F</bold>) MLN4924 treatment has no effect on UBXN7 interaction with ubiquitylated-proteins or with p97. (<bold>E</bold>, <bold>F</bold>) Flag-UBXN7 was immunoprecipitated from HeLa cells treated with MG132, MLN4924, or a combination of the two. The indicated proteins were detected using specific antibodies.</p>
          </caption>
          <graphic xlink:href="1741-7007-10-36-2"/>
        </fig>
      </sec>
      <sec>
        <title>The UIM motif of UBXN7 is required to engage the NEDD8 modification on cullins</title>
        <p>Because UBXN7 preferentially interacted with neddylated-CUL2 and cullin-neddylation was a prerequisite for the interaction to occur, we became intrigued with the possibility that the NEDD8 modification on cullins might be directly involved in recruiting UBXN7. We therefore turned our attention to UBXN7 and the various domains that are part of its structure. At the N-terminus of UBXN7 there is a UBA domain, followed by a UAS domain of unknown function, a UIM motif and a UBX domain at the C-terminus (Figure <xref ref-type="fig" rid="F3">3A</xref>). To investigate whether any of these domains was required for UBXN7 interaction with CUL2, we compared the ubiquitin- and CUL2-binding capability of several UBXN7 variants, including wild-type, a point mutant in the UBX domain (P459G), and truncation mutants lacking either the UBA, the UAS, the UIM or the UBX domain (Figures <xref ref-type="fig" rid="F3">3B</xref> and <xref ref-type="fig" rid="F3">3C</xref>). The deletion of the UAS domain had largely no effect on UBXN7 interaction with ubiquitin, p97 or CUL2. Both ÎUBA and ÎUIM truncation mutants were partially defective in ubiquitin-binding (Figure <xref ref-type="fig" rid="F3">3B</xref>, compare lanes 2, 4 with 1). Interestingly, while ÎUBA had wild-type capability to bind CUL2 (Figure <xref ref-type="fig" rid="F3">3C,</xref>compare lanes 1 and 2), the ÎUIM truncation caused a pronounced reduction in CUL2-binding (Figure <xref ref-type="fig" rid="F3">3C</xref>, compare lanes 1 and 4). These results suggested that the UIM motif was required for CUL2-binding, while the UBA domain was not.</p>
        <fig id="F3" position="float">
          <label>Figure 3</label>
          <caption>
            <p><bold>An intact UIM motif is necessary for UBXN7 interaction with neddylated-CUL2</bold>. (<bold>A</bold>) Schematic representation of human UBXN7 highlighting its various domains. (<bold>B</bold>-<bold>D</bold>) Wild-type or mutant Flag-UBXN7 was immunoprecipitated from HeLa cells. The indicated proteins were detected using specific antibodies in the immunoprecipitates (left) and the input cell extracts (right). (<bold>B</bold>) Either UBA- or UIM-deletion caused a reduction in ubiquitin-binding to UBXN7. UBX-deletion or a point mutation in this domain (P459G) abolished p97-binding and severely impaired the interaction with ubiquitylated proteins (left panel). (<bold>C</bold>) UIM-deletion, but not other mutations, caused a strong reduction in CUL2-binding to UBXN7 (left panel) and abolished the CUL2 up-shift caused by UBXN7 over-expression (right panel). (<bold>D</bold>) Point mutations within the UIM motif at Ser297 caused a defect in CUL2-binding to UBXN7 similar to UIM-deletion. p97-binding was not affected by these mutations (left panel).</p>
          </caption>
          <graphic xlink:href="1741-7007-10-36-3"/>
        </fig>
        <p>As expected, both UBX-deletion and a point mutation in this domain (P459G) abolished p97 binding (Figure <xref ref-type="fig" rid="F3">3B</xref>). Surprisingly, these mutations also affected ubiquitin-binding, suggesting that they have a broad effect on UBXN7 function, possibly by altering the overall structure of the protein. Although UBX mutants were severely defective in p97- and ubiquitin-binding, they largely retained their ability to interact with CUL2 (Figure <xref ref-type="fig" rid="F3">3C</xref>), supporting the notion that UBXN7 binding to CUL2 is independent of its binding to p97 or ubiquitylated-proteins.</p>
        <p>Consistent with the reduced binding of UBXN7 ÎUIM to CUL2, over-expression of this mutant failed to cause an up-shift of CUL2 to the neddylated form (Figure <xref ref-type="fig" rid="F3">3C</xref>, compare lanes 8 and 11). In effect, CUL2 migration in cells expressing UBXN7 ÎUIM was similar to untransfected cells (Figure <xref ref-type="fig" rid="F3">3C</xref>, lanes 11 and 14).</p>
        <p>Various residues within the UIM motif are essential for its interaction with ubiquitin [<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B32">32</xref>]. We found that mutating Ser297 to either Ala or His causes a defect in binding neddylated-CUL2 similar to UIM deletion (Figure <xref ref-type="fig" rid="F3">3D</xref>, compare lanes 4, 5 with 3). We therefore conclude that both UIM-deletion and point mutations in this motif negatively affect UBXN7 interaction with neddylated-cullin.</p>
        <p>To further substantiate the ability of the UIM motif in UBXN7 to interact with NEDD8 rather than ubiquitin we performed <italic>in vitro </italic>binding assays to NEDD8- or ubiquitin-agarose. Wild-type UBXN7 was pulled-down efficiently with both types of beads (Figure <xref ref-type="fig" rid="F4">4A</xref>). Deletion of the UIM motif caused a marked reduction in NEDD8-binding and had no effect on ubiquitin-binding, while UBA-deletion abolished ubiquitin-binding and caused some reduction in NEDD8-binding as well. These data strongly support the notion that the UIM motif of UBXN7 is specialized in recognizing NEDD8 and can directly engage the NEDD8 modification on cullins.</p>
        <fig id="F4" position="float">
          <label>Figure 4</label>
          <caption>
            <p><bold>UBXN7 directly interacts with NEDD8 and cullins <italic>in vitro</italic></bold>. (<bold>A</bold>) The UIM motif of UBXN7 directly recognizes NEDD8. The deletion of the UIM motif exclusively reduces UBXN7 binding to NEDD8 while deletion of the UBA domain abolishes the interaction with ubiquitin. NEDD8 or ubiquitin-agarose beads were incubated with the indicated recombinant variants of UBXN7. (<bold>B</bold>) Wild-type UBXN7 efficiently pulls-down CUL2 irrespective of its modification status (left panel). Bacterially expressed Flag-UBXN7 was pre-incubated with full-length CUL2 either unmodified or partially neddylated and then immunoprecipitated using anti-Flag beads. (<bold>C</bold>) The <italic>in vitro </italic>interaction of UBXN7 with full-length CUL2 is not affected by UIM deletion. Wild-type or UIM-deleted Flag-UBXN7 was incubated with a mixture of neddylated and non-neddylated CUL2 and then immunoprecipitated as in (B). (<bold>D</bold>) Cullin-neddylation increases the binding of full-length and UBA-deleted UBXN7, but not of the UIM-deleted mutant. GSH-beads coated with either non-neddylated or a mixture of neddylated and non-neddylated CUL1(342-776)/GST-RBX1 were incubated with the indicated UBXN7 variants. Naked GSH-beads were used as a control. The Flag western blot in the right panel shows similar input levels for the three UBXN7 variants.</p>
          </caption>
          <graphic xlink:href="1741-7007-10-36-4"/>
        </fig>
      </sec>
      <sec>
        <title>UBXN7 interacts with cullin-RING complexes <italic>in vitro</italic></title>
        <p>To check whether UBXN7 could interact with cullin complexes <italic>in vitro</italic>, we used anti-Flag beads to immunoprecipitate Flag-tagged UBXN7 incubated with either unmodified CUL2 or CUL2 that was <italic>in vitro </italic>neddylated. Only a fraction of CUL2 became neddylated, because RBX1 was present in substoichiometric amounts in our CUL2 preparation. We found that wild-type UBXN7 could interact efficiently with CUL2 irrespective of its neddylation status (Figure <xref ref-type="fig" rid="F4">4B</xref>). A UBXN7 variant lacking the UIM motif was equally proficient in interacting with both forms of CUL2 (Figure <xref ref-type="fig" rid="F4">4C</xref>). Under these conditions UBXN7 interaction with CUL2 does not appear to depend strictly on either UIM or NEDD8. To eliminate potential binding sites in the N-terminal half of the cullin, we then used bacterially expressed GST-RBX1 in complex with the C-terminal fragment of CUL1 (amino acids 324-776) [<xref ref-type="bibr" rid="B33">33</xref>]. The CUL1/RBX1 complex immobilized on glutathione-beads was either neddylated or exposed to a mock neddylation-mix without NEDD8. All UBXN7 variants tested interacted to some degree with the non-neddylated CUL1 fragment (Figure <xref ref-type="fig" rid="F4">4D</xref>). Upon CUL1-neddylation, the interaction with wild-type UBXN7 and also with the ÎUBA mutant was enhanced, while the interaction with the ÎUIM mutant remained unaffected (Figure <xref ref-type="fig" rid="F4">4D</xref>). We therefore established that UBXN7 can directly interact with cullins <italic>in vitro </italic>and confirmed that the UIM-NEDD8 contact has a contribution, albeit not as important as observed using cell extracts.</p>
      </sec>
      <sec>
        <title>UBXN7 over-expression causes HIF1Î± accumulation in a UIM-dependent manner</title>
        <p>Because various UBXN7 mutants had altered ability to interact with ubiquitylated-proteins or with CUL2, we checked whether their expression in the cell might have any consequence on the levels of HIF1Î±, which is a CRL2 substrate [<xref ref-type="bibr" rid="B27">27</xref>] and also interacts with UBXN7 [<xref ref-type="bibr" rid="B15">15</xref>]. Over-expression of wild-type UBXN7 caused a significant accumulation of HIF1Î± in its non-ubiquitylated form (Figure <xref ref-type="fig" rid="F5">5A</xref>, compare lanes 1 and 2). Most importantly, this effect was dependent on the UIM motif, as HIF1Î± levels in cells over-expressing a UIM-deleted version of UBXN7 were similar to untransfected cells (Figure <xref ref-type="fig" rid="F5">5A</xref>, lanes 1 and 5). In contrast, the levels of the CRL2 subunits CUL2, VHL, elongin C and RBX1 remained unaffected (Figure <xref ref-type="fig" rid="F5">5A</xref>). UBXN7 is unique in its ability to cause UIM-dependent accumulation of HIF1Î±, as over-expression of another UIM-containing ubiquitin-receptor, the proteasome subunit PSMD4, had no effect on HIF1Î± levels (Figure <xref ref-type="fig" rid="F5">5B</xref>).</p>
        <fig id="F5" position="float">
          <label>Figure 5</label>
          <caption>
            <p><bold>UBXN7 over-expression causes HIF1Î± accumulation in a UIM-dependent manner</bold>. (<bold>A</bold>) Non-ubiquitylated HIF1Î± accumulates in cells over-expressing wild-type Flag-UBXN7, but not in cells expressing a UIM-deleted version. 10 Î¼M MG132 was added two hours prior to cell lysis to facilitate HIF1Î± detection. UBXN7 over-expression had no effect on CRL2 subunit levels. (<bold>B</bold>) Over-expression of another UIM-containing protein, PSMD4, does not alter HIF1Î± levels. (<bold>C, D</bold>) UIM-dependent accumulation of non-ubiquitylated HIF1Î± upon UBXN7 over-expression is also observed in the absence of proteasome inhibition (right panels). Wild-type UBXN7 interacted with HIF1Î± at various degrees of ubiquitylation, while UIM-defective UBXN7 (upon UIM deletion or point mutation at Ser297) only interacted with slow-migrating, poly-ubiquitylated HIF1Î± (left panels). The corresponding Flag, CUL2 and p97 western blots for the experiment in (C) are shown in figure 3D. (<bold>D</bold>) UBXN7 mutated at Ser288 within the UIM motif binds CUL2 (left panel) and causes HIF1Î± accumulation (right panel), similar to the wild-type protein. The indicated proteins were detected using specific antibodies.</p>
          </caption>
          <graphic xlink:href="1741-7007-10-36-5"/>
        </fig>
        <p>To facilitate HIF1Î± detection, for the experiments shown in Figures <xref ref-type="fig" rid="F5">5A</xref> and <xref ref-type="fig" rid="F5">5B</xref>, the cells were subjected to brief inhibition of the proteasome activity prior to cell lysis. However, UIM-dependent accumulation of HIF1Î± upon UBXN7 over-expression could also be observed in the absence of MG132 treatment (Figures <xref ref-type="fig" rid="F5">5C</xref> and <xref ref-type="fig" rid="F5">5D</xref>, right panels). Point mutations at Ser297 in the UIM motif that negatively affect CUL2-binding (Figure <xref ref-type="fig" rid="F3">3D</xref>) also abolished HIF1Î± accumulation, similar to UIM-deletion (Figure <xref ref-type="fig" rid="F5">5C</xref>, right panel).</p>
        <p>Previous reports identified a phosphorylation site within the UIM motif of human UBXN7 at Ser288 [<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B35">35</xref>]. We therefore created a phosphorylation-defective (S288A) and a phosphorylation-mimicking mutant (S288D) of that residue to verify whether phosphorylation of Ser288 might regulate UIM function. Both mutants behaved similar to wild-type with respect to CUL2- and HIF1Î±-binding (Figure <xref ref-type="fig" rid="F5">5D</xref>). They also caused HIF1Î± accumulation, much like wild-type UBXN7 (Figure <xref ref-type="fig" rid="F5">5D</xref>, right panel). Therefore, phosphorylation at Ser288 does not appear to be critical for UIM function.</p>
        <p>Interestingly, the defect in CUL2-binding observed for the UIM-defective mutants correlated with a complete loss of binding to non- or oligo-ubiquitylated HIF1Î± (Figure <xref ref-type="fig" rid="F5">5C</xref>). Nonetheless, these mutants retained the ability to interact with poly-ubiquitylated HIF1Î± (that is, the slowest migrating forms of HIF1Î±), presumably via the UBA domain.</p>
      </sec>
      <sec>
        <title>Long ubiquitin-chains on HIF1Î± cause reduced ubiquitin-receptor selectivity</title>
        <p>We previously observed that HIF1Î± carrying long ubiquitin-chains can interact, albeit inefficiently, with UBA-UBX proteins other than UBXN7 [<xref ref-type="bibr" rid="B15">15</xref>]. Consistent with it being pre-docked on the CRL2 complex, UBXN7 interacted with HIF1Î± at various degrees of ubiquitylation, from non- or oligo-ubiquitylated to poly-ubiquitylated (Figure <xref ref-type="fig" rid="F6">6A</xref>). In contrast, another UBA-UAS-UBX protein, FAF1, only interacted with slower migrating HIF1Î± (Figure <xref ref-type="fig" rid="F6">6A</xref>), similar to UBXN7 lacking the UIM motif (Figure <xref ref-type="fig" rid="F5">5D</xref>).</p>
        <fig id="F6" position="float">
          <label>Figure 6</label>
          <caption>
            <p><bold>HIF1Î± carrying long ubiquitin-chains becomes promiscuous in its interaction with ubiquitin-receptors</bold>. (<bold>A</bold>) FAF1 interacts, albeit inefficiently, with HIF1Î± carrying long ubiquitin-chains (top panel). Flag-UBXN7 or Flag-FAF1 was immunoprecipitated from HeLa cells treated with 10 Î¼M MG132, 1 Î¼M MLN4924, or a combination of the two for two hours. (<bold>B</bold>) Flag-UBXN7 (green) localizes to the nucleus of HeLa cells. The DNA was stained with DAPI (blue). The scale bar represents 15 Î¼m. (<bold>C</bold>) RAD23B interacts with slower-migrating, poly-ubiquitylated HIF1Î± (top panel). Flag-UBXN7 or Flag-RAD23B was immunoprecipitated from HeLa cells using anti-Flag beads. The indicated proteins were detected by western blotting using specific antibodies.</p>
          </caption>
          <graphic xlink:href="1741-7007-10-36-6"/>
        </fig>
        <p>Flag-UBXN7 was found exclusively in the nuclei of HeLa cells (Figure <xref ref-type="fig" rid="F6">6B</xref>). RAD23B, another UBA-domain ubiquitin-receptor also localizes to the nuclear compartment [<xref ref-type="bibr" rid="B36">36</xref>,<xref ref-type="bibr" rid="B37">37</xref>] and this prompted us to check whether it may also interact with HIF1Î±. Like FAF1, RAD23B was able to co-immunoprecipitate HIF1Î± carrying longer ubiquitin-chains (Figure <xref ref-type="fig" rid="F6">6C</xref>). Hence, as the ubiquitin-chains get longer, the substrate appears less selective in its interaction with ubiquitin-receptors. Our observations suggest that UBXN7 targets mainly the nuclear pool of HIF1Î± and it may compete with RAD23B for ubiquitylated-HIF1Î± in the nucleus.</p>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <sec>
        <title>UBXN7 interaction with cullins requires neddylation and is independent of the ubiquitylated substrate</title>
        <p>Multiple lines of evidence indicate that ubiquitin/substrate-binding and cullin-binding to UBXN7 are two independent events: (1) inhibition of the ubiquitin-E1 strongly reduces ubiquitin-binding, but it has no effect on CUL2-binding to UBXN7; (2) UBXN7 interaction with HIF1Î±/VHL is transient and strongly enhanced upon proteasome inhibition while UBXN7 interaction with the core CRL2 complex is stable; (3) UBA-domain deletion reduces ubiquitin-binding to UBXN7, but it does not affect the interaction with CUL2.</p>
        <p>Furthermore, several observations support the notion that neddylation is necessary for UBXN7 interaction with cullins: (1) CUL2 mutants defective to varying degrees in getting neddylated are similarly defective in UBXN7 binding; (2) chemical inhibition of the NEDD8-E1 abolishes the interaction of UBXN7 with multiple cullins; (3) <italic>in vitro </italic>neddylation of a CUL1-fragment stimulates its interaction with bacterially-expressed UBXN7, in a UIM-dependent manner. <italic>In vitro</italic>, UBXN7 can interact with non-neddylated cullins suggesting that UIM-NEDD8 may not be the only link between UBXN7 and CRLs. As we used simplified CRLs containing only the cullin and RBX1, these other binding determinants might be particularly accessible, thereby relinquishing the strict requirement for neddylation that we observed for the native form of CUL2 present in cell extracts.</p>
      </sec>
      <sec>
        <title>UBXN7, one domain for each interaction</title>
        <p>The UBX domain has a ubiquitin-like structure [<xref ref-type="bibr" rid="B38">38</xref>] and is widely used by p97 co-factors to interact with p97 N-termini [<xref ref-type="bibr" rid="B13">13</xref>]. Our analysis confirms that the UBX domain is the only domain of UBXN7 required for p97 binding.</p>
        <p>Both UBA and UIM have been characterized extensively as ubiquitin-binding modules [<xref ref-type="bibr" rid="B39">39</xref>]. NEDD8 and ubiquitin sequences are 57% identical resulting in a very similar three-dimensional fold, termed the ubiquitin superfold. Most importantly, the hydrophobic surface of ubiquitin (formed by Leu8, Ile44, His68 and Val70) that interacts with ubiquitin-binding domains such as UBA [<xref ref-type="bibr" rid="B40">40</xref>] and UIM [<xref ref-type="bibr" rid="B41">41</xref>] is conserved in NEDD8 [<xref ref-type="bibr" rid="B42">42</xref>]. UBA and UIM interact with NEDD8 <italic>in vitro </italic>[<xref ref-type="bibr" rid="B43">43</xref>,<xref ref-type="bibr" rid="B44">44</xref>] and also with another domain from the ubiquitin superfold family, the UBL domain [<xref ref-type="bibr" rid="B45">45</xref>]. In principle, either UBA or UIM could serve as a docking site for neddylated-cullins.</p>
        <p>We show that within UBXN7, UBA and UIM play distinct roles. In cell extracts, the UBXN7 mutant lacking the UBA domain is fully competent in interacting with cullins, thus ruling out the involvement of this domain in cullin-binding. This mutant is the least competent in ubiquitin-binding, but it is not fully defective. It is possible that, in this case, ubiquitin-binding is not direct, but mediated by the UIM motif bound to cullins. In contrast, UBXN7 lacking the UIM motif or carrying point mutations therein is strongly defective in cullin-binding. The residual CUL2-binding observed for the ÎUIM mutant may be mediated by its UBA-dependent interaction with ubiquitylated substrates of CRL2. Indeed this mutant retains the ability to interact with HIF1Î± carrying long ubiquitin-chains. We argue that the UIM motif contributes to the direct binding of UBXN7 to neddylated-cullins. This conclusion is strongly supported by our <italic>in vitro </italic>binding assays where a UBXN7 variant lacking the UIM motif becomes defective in binding to NEDD8- but not ubiquitin-agarose. This experiment also clarifies that the UIM motif recognizes the NEDD8 modification <italic>per se </italic>rather than the neddylated conformation of cullins.</p>
        <p>The data presented here suggest that each of the three domains found in UBXN7 enables a specific interaction to occur. Thus, the UIM motif allows docking of UBXN7 on neddylated-cullins, the UBA domain is required for binding ubiquitylated-protein substrates, and the UBX domain recruits the p97 complex (Figure <xref ref-type="fig" rid="F7">7</xref>). Future work will reveal the role played by the UAS domain.</p>
        <fig id="F7" position="float">
          <label>Figure 7</label>
          <caption>
            <p><bold>UBXN7 docks on neddylated cullins using its UIM motif</bold>. Each domain in UBXN7 mediates a specific interaction: the UBA domain interacts with ubiquitylated HIF1Î±, the UIM motif anchors the neddylated CRL complex and the UBX domain recruits the p97/NPL4/UFD1 complex.</p>
          </caption>
          <graphic xlink:href="1741-7007-10-36-7"/>
        </fig>
      </sec>
      <sec>
        <title>Processivity versus selectivity in CRL-dependent degradation</title>
        <p>Having established that UBXN7 can directly interact with neddylated CRL complexes, a key question is whether this interaction might have any effect on the ubiquitin-ligase activity of CRLs.</p>
        <p>The data presented here lead us to speculate that UBXN7 is not only a ubiquitin-binding adaptor for p97, but it may also embody a novel mechanism of CRL inhibition. This would be in agreement with our previous observation that UBXN7 depletion by siRNA causes a reduction in HIF1Î± levels and not HIF1Î± accumulation as would be expected were it simply mediating HIF1Î± interaction with p97 [<xref ref-type="bibr" rid="B15">15</xref>].</p>
        <p>Our finding that UBXN7 over-expression causes the accumulation of HIF1Î± mostly in its non-ubiquitylated form suggests that the UIM-NEDD8 interaction would have a negative effect on ubiquitin-chain elongation, that is, reduce the processivity of the CRL ubiquitin-ligase. UBXN7 over-expression causes not only HIF1Î± accumulation, but also converts CUL2 to its neddylated form. Because both effects are entirely dependent on the UIM motif, it is tempting to propose that by sequestering CUL2 in its neddylated form, UBXN7 might sterically hinder the transition of the CRL complex to an open conformation and thereby mitigate the positive effect NEDD8 has on CRL E3 activity.</p>
        <p>We find that ubiquitin-receptor selectivity is compromised when HIF1Î± carries long ubiquitin-chains. Hence, we suggest that reduced CRL processivity would favor p97 recruitment to the UBX-domain of UBXN7 rather than recruitment of alternative ubiquitin-receptors to a fast-growing ubiquitin chain. Through its prior docking on the neddylated-CRL, UBXN7 would be ideally poised to modulate substrate-ubiquitylation and to shift the balance towards p97 recruitment.</p>
      </sec>
      <sec>
        <title>UBXN7 recruits p97 to nuclear HIF1Î±</title>
        <p>Employing p97 complexes as the ubiquitin-receptor of choice is particularly important in the nucleus, where HIF1Î± forms complexes with HIF1Î² and associates with the promoters of its target genes [<xref ref-type="bibr" rid="B46">46</xref>-<xref ref-type="bibr" rid="B48">48</xref>]. Among the various ubiquitin-receptors, p97 uniquely provides the segregase activity required to release nuclear HIF1Î± from its protein partners and/or from chromatin prior to its degradation. Endogenous HIF1Î± is found in the nuclei of normoxic cells from normal and tumor tissues [<xref ref-type="bibr" rid="B49">49</xref>-<xref ref-type="bibr" rid="B51">51</xref>] and poly-ubiquitylated HIF1Î± is detected exclusively in the nuclei of normoxic HeLa cells [<xref ref-type="bibr" rid="B52">52</xref>]. Consistent with the notion that UBXN7/p97 targets specifically nuclear HIF1Î±, we find that Flag-UBXN7 localizes to the nucleus of normoxic HeLa cells.</p>
      </sec>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusions</title>
      <p>Herein we show that among the ubiquitin-binding adaptors of p97, UBXN7 has the unique ability to directly dock onto neddylated cullins. This function depends on the UIM motif that is only found in the UBXN7 co-factor of p97. Furthermore, UBXN7 interaction with neddylated CUL2 appears to negatively affect its ubiquitin-ligase activity as UBXN7 over-expression causes the accumulation of non-ubiquitylated HIF1Î± in a UIM-dependent manner.</p>
      <p>It has been puzzling why p97 has such a multitude of ubiquitin-binding co-factors, for example, NPL4, UFD1, various UBA-UBX proteins, PLAA. Our data indicate that the role of UBXN7 as a substrate-binding adaptor for p97 is secondary to its ability to interact with CRLs and possibly to modulate their activity. UBXN7 interaction with cullins does not require p97, while UBXN7 interaction with NPL4/UFD1 is mediated by p97 [<xref ref-type="bibr" rid="B15">15</xref>], suggesting that UBXN7 acts upstream of NPL4/UFD1 in the p97 pathway of ubiquitin-dependent degradation. It is feasible to assume that various adaptors of p97 function in a sort of relay and their temporal succession is dictated by functions other than mere ubiquitin recognition. Future work will tell for how many of the above proteins their ubiquitin-binding capacity is just one facet of a more complex function.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <sec>
        <title>Cloning Information</title>
        <p>Human UBXN7 [GenBank: <ext-link ext-link-type="gen" xlink:href="NM_015562">NM_015562</ext-link>] was amplified from EST IMAGE 5294894. For mammalian expression, wild-type and mutant UBXN7 variants were subcloned as BamH1/Not1 inserts into pCMV5-Flag. For bacteria expression, UBXN7 variants were subcloned into a modified pGEX6P-1 vector containing a TEV protease site and a Flag tag downstream of the GST. Human CUL2 [GenBank: <ext-link ext-link-type="gen" xlink:href="NM_003591">NM_003591</ext-link>] and RAD23B [GenBank: <ext-link ext-link-type="gen" xlink:href="NM_002874.3">NM_002874.3</ext-link>] were amplified from EST IMAGE 4104375 and 3906269, respectively, for subcloning into pCMV5-Flag as BamH1/Not1 inserts. Human FAF1 [GenBank: <ext-link ext-link-type="gen" xlink:href="NM_007051.2">NM_007051.2</ext-link>] and PSMD4 [GenBank: <ext-link ext-link-type="gen" xlink:href="NM_002810.2">NM_002810.2</ext-link>] were amplified from EST IMAGE 5928559 and 6285035, respectively, for subcloning into pCMV5-Flag as Sal1/Not1 inserts. To construct the baculovirus vector for dual expression of GST-CUL2 and HIS<sub>6</sub>-RBX1, human CUL2 was subcloned as a BamH1/Not1 insert into the P<sub>PH </sub>driven cassette of pFastBac-Dual-GST. RBX1 [GenBank: <ext-link ext-link-type="gen" xlink:href="NM_014248.2">NM_014248.2</ext-link>] was amplified from EST IMAGE 3138751 adding an Nhe1 site and 6HIS tag on the 5' primer and a Kpn1 site on the 3' primer and subcloned into the P<sub>P10 </sub>driven cassette of pFastBac-Dual-GST-CUL2.</p>
        <p>PCR reactions were carried out using KOD Hot Start DNA Polymerase (Merck Millipore, Darmstadt, Germany). All full-length PCR products were cloned into pSc-B (Agilent Technologies, Santa Clara, CA, USA) and fully sequenced prior to further subcloning. All mutations and deletions were made following the Quickchange method (Agilent Technologies), but using KOD Hot Start DNA Polymerase. DNA sequencing was performed by the Sequencing Service at the College of Life Sciences (CLS), University of Dundee.</p>
      </sec>
      <sec>
        <title>Cell Extracts and Immunoprecipitation</title>
        <p>For immunoprecipitation experiments, the cells were lysed in buffer A (50 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES)/KOH, pH 7.2; 5 mM Mg(OAc)<sub>2</sub>; 70 mM KOAc; 0.2% Triton X-100; 10% glycerol; 0.2 mM ethylenediaminetetraacetic acid (EDTA); protease inhibitors) and incubated with anti-UBXN7 antibodies crosslinked to Protein A-agarose or anti-Flag beads (Sigma, Saint Louis, MO, USA). For the experiment in Figure <xref ref-type="fig" rid="F5">5D</xref>, PhosSTOP phosphatase inhibitor (Roche. Mannheim, Germany) was also added to the lysis buffer.</p>
        <p>Total extracts were prepared using buffer B (50 mM HEPES/KOH, pH 7.2; 400 mM NaCl; 1% NP-40; 0.2 mM EDTA; 10% glycerol; protease inhibitors) to facilitate extraction of nuclear HIF1Î±.</p>
      </sec>
      <sec>
        <title>Antibodies and Chemicals</title>
        <p>The following antibodies were used for protein detection by western blotting: mouse anti-Flag M2 (Sigma), mouse anti-ubiquitin FK2 (Enzo, Farmingdale, NY, USA), mouse anti-p97 (Fitzgerald, North Acton, MA, USA), mouse anti-CUL3, mouse anti-elongin C (BD Transduction Laboratories, San Jose, CA, USA), rabbit anti-CUL4A (Cell Signalling, Danvers, MA, USA), rabbit and mouse anti-CUL1, rabbit anti-CUL2, rabbit anti-NEDD8 (Invitrogen, Camarillo, CA, USA), rabbit anti-RBX1 (Thermo, Fremont, CA, USA), rabbit anti-VHL (Santa Cruz Biotechnology, Santa Cruz, CA, USA), rabbit anti-HIF1Î± (Novus, Littleton, CO, USA), rabbit anti-UBXN7 (courtesy of Millipore, Billerica, MA, USA). MG132 (Enzo) was added at 10 Î¼M to the tissue culture media for two hours prior to cell lysis. The Division of Signal Transduction Therapy (DSTT) at the CLS, University of Dundee synthesized MLN4924, as described previously [<xref ref-type="bibr" rid="B53">53</xref>]. The cells were incubated with 1 Î¼M MLN4924 for two hours.</p>
      </sec>
      <sec>
        <title>Recombinant Protein Expression and Purification</title>
        <p>The Protein Production and Assay Development Team (PPADT) at SCILLS produced the various recombinant proteins in bacteria, as follows. Expression vectors for full length, UBA- or UIM-deleted UBXN7 were transformed into BL21 DE3 cells. Overnight cultures were grown in LB medium (1% tryptone, 0.5% yeast extract, 1% NaCl) supplemented with carbenicillin. Autoinduction medium was inoculated and the cells were left to grow at 37Â°C until the OD<sub>600 </sub>reached about 1.5. The temperature was then dropped to 15Â°C and the cells were left for about 16 hours to express the protein. The cells were collected by centrifugation and resuspended in 50 mM Tris-HCl pH 7.5, 250 mM NaCl, 0.4% Triton X-100, 0.1 mM EDTA, 0.1 mM ethylene glycol tetraacetic acid (EGTA), 1 mM dithiothreitol (DTT) and protease inhibitors. The suspension was sonicated and the insoluble material was sedimented by centrifugation at 4Â°C, 28,000 g for 20 minutes. The supernatant was incubated with GSH-sepharose for one hour. The sepharose was washed four times and UBXN7 was recovered upon cleavage with TEV protease. The proteins were further purified by chromatography over a Superdex 75 column after which protein purity exceeded 90%.</p>
        <p>The vector expressing Flag-CUL1(324-776)/GST-HA-RBX1 [<xref ref-type="bibr" rid="B33">33</xref>] was also transformed into BL21 cells, but grown in LB/ampicillin and induced with 0.1 mM isopropyl-beta-D-thiogalactopyranoside (IPTG) at an OD<sub>600 </sub>of 0.7. This was then left to express at 15Â°C overnight and the lysate was prepared as described above.</p>
        <p>The dual expression vector encoding GST-CUL2/HIS<sub>6</sub>-RBX1 was used to generate recombinant baculoviruses using the Bac-to-Bac system (Invitrogen) following the manufacturer's protocol. These baculoviruses were used to infect <italic>Spodoptera frugiperda </italic>21 cells (1.5 Ã 10<sup>6</sup>/ml) at a multiplicity of infection of 5 and the infected cells were harvested 48 hours post-infection. GST-CUL2/RBX1 was purified on GSH-Sepharose and dialysed into 50 mM Tris-HCl pH 7.5, 0.1 mM EGTA, 150 mM NaCl, 270 mM sucrose, 0.03% Brij-35, 0.1% 2-mercaptoethanol, 1 mM benzamidine, 0.1 mM phenylmethylsulfonyl fluoride (PMSF).</p>
      </sec>
      <sec>
        <title><italic>In Vitro </italic>Binding Assays</title>
        <p>The Flag-CUL1(324-776)/GST-HA-RBX1 complex was immobilized on GSH-sepharose (GE). For each binding assay, 10 Î¼l beads carrying approximately 1 Î¼g CUL1/RBX1 were incubated for 30 minutes at 30Â°C with a neddylation reaction mix containing NEDD8 E1 (PPADT, SCILLS), NEDD8 E2 (Ubiquigent, Dundee, UK), NEDD8 and ERS (BostonBiochem, Cambridge, MA, USA) in buffer C (50 mM HEPES/KOH, pH 7.5; 60 mM KOAc; 5 mM MgCl<sub>2</sub>; 5% glycerol, 1 mM DTT). Mock neddylation reactions were performed in parallel by omitting NEDD8 from the mixture. The beads were then washed and incubated for one hour with 3 Î¼g of wild-type or mutant Flag-UBXN7 in buffer C without DTT and supplemented with 0.1% Triton X-100 (buffer D). After washing the beads, the bound proteins were eluted with Laemmli buffer. The binding assays were also performed using naked beads to account for non-specific UBXN7 binding to the beads.</p>
        <p>GST was cleaved off CUL2 with PreScission protease and the resulting CUL2/RBX1 was neddylated as above. CUL2/RBX1 (1.5 Î¼g) was pre-incubated with 1.5 Î¼g Flag-UBXN7 (approximately 1.5 times molar excess to CUL2) for 30 minutes, followed by one hour incubation with 10 Î¼l anti-Flag beads in buffer D. The proteins bound to beads were eluted by boiling in Laemmli buffer.</p>
        <p>Wild-type or mutant UBXN7 (25 Î¼g) was incubated for one hour with 10 Î¼l NEDD8- or ubiquitin-agarose (BostonBiochem) in buffer D and the bound proteins were eluted as above.</p>
      </sec>
      <sec>
        <title>Immunofluorescence Staining and Microscopy</title>
        <p>For Flag-UBXN7 immunostaining, cells were grown on coverslips and fixed with ice-cold methanol for six minutes at -20Â°C. Cells were then blocked in 1% BSA/PBS for 30 minutes and subsequently incubated with mouse anti-Flag M2 (Sigma) antibodies in 3% BSA/PBS, for one hour at room temperature. After washing with PBS, cells were incubated with donkey anti-mouse FITC-conjugated antibodies (Jackson ImmunoResearch, West Grove, PA, USA) for 45 minutes. The cell nuclei were stained with 4',6-diamidino-2-phenylindole (DAPI, Invitrogen). The coverslips were mounted onto glass slides using hydromount (National Diagnostics, Atlanta, GA, USA).</p>
        <p>Images were obtained with a DeltaVision Spectris microscope (Applied Precision), using a CoolSNAP HQ camera (Roper) and a 60 Ã 1.4 NA objective (Olympus). The SoftWorx software (Applied Precision) was used for acquisition and deconvolution.</p>
      </sec>
    </sec>
    <sec>
      <title>Abbreviations</title>
      <p>ATP: adenosine triphosphate; BSA: bovine serum albumin; CLS: College of Life Sciences; CRL: cullin-RING E3 ligase; CRL2: CUL2-based CRL; DAPI: 4',6-diamidino-2-phenylindole; DSTT: Division of Signal Transduction Therapy; DTT: dithiothreitol; EDTA: ethylenediaminetetraacetic acid; EGTA: ethylene glycol tetraacetic acid; ERS: energy regeneration solution; FITC: fluorescein isothiocyanate; GSH: glutathione; GST: glutathione S-transferase; HECT: homologous to E6-AP carboxyl terminus: HEPES: N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid; IPTG: isopropyl-beta-D-thiogalactopyranoside; KOAc: potassium acetate; KOH: potassium hydroxide; LB: Luria-Bertani media; Mg(OAc)<sub>2</sub>: magnesium acetate; NaCl: sodium chloride; OD: optical density; PBS: phosphate buffered saline; PCR: polymerase chain reaction; PMSF: phenylmethylsulfonyl fluoride; PPADT: Protein Production and Assay Development Team; RING: really interesting new gene; SCILLS: Scottish Institute for Cell Signalling; siRNA: small interfering RNA; TEV: Tobacco Etch virus; UAS: domain of unknown function; UBA: ubiquitin-associated domain; UBL: ubiquitin-like protein; UBX: ubiquitin regulatory X domain; UIM: ubiquitin-interacting motif.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The authors declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors' contributions</title>
      <p>SB performed the experiments shown in Figures <xref ref-type="fig" rid="F1">1D</xref>, <xref ref-type="fig" rid="F3">3D</xref>, <xref ref-type="fig" rid="F5">5B, C</xref>, <xref ref-type="fig" rid="F6">6B</xref> and <xref ref-type="fig" rid="F6">6C</xref>. GA performed all the other experiments, conceived the study and wrote the manuscript. ZG and NW did the cloning. AK coordinated expression and purification of the proteins used for <italic>in vitro </italic>assays. All authors read and approved the final manuscript.</p>
    </sec>
  </body>
  <back>
    <sec>
      <title>Acknowledgements</title>
      <p>We would like to thank J. Hastie and the PPAD team for recombinant protein expression and purification, N. Shpiro for MLN4924 synthesis, T. Kurz lab, J. Bett, S. Rocha, and Ubiquigent for sharing reagents, S. Swift for help with microscopy, and D. Wright for tissue culture assistance. We are grateful to P. Cohen for critical comments on the manuscript and to D. Alessi, R. Hjerpe, and T. Kurz for helpful advice. The research in G.A. lab is supported by a grant from the Scottish Government to SCILLS.</p>
    </sec>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hershko</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Heller</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Elias</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ciechanover</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Components of ubiquitin-protein ligase system. Resolution, affinity purification, and role in protein breakdown</article-title>
          <source>J Biol Chem</source>
          <year>1983</year>
          <volume>258</volume>
          <fpage>8206</fpage>
          <lpage>8214</lpage>
          <pub-id pub-id-type="pmid">6305978</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Verma</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Oania</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Graumann</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Deshaies</surname>
            <given-names>RJ</given-names>
          </name>
          <article-title>Multiubiquitin chain receptors define a layer of substrate selectivity in the ubiquitin-proteasome system</article-title>
          <source>Cell</source>
          <year>2004</year>
          <volume>118</volume>
          <fpage>99</fpage>
          <lpage>110</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2004.06.014</pub-id>
          <pub-id pub-id-type="pmid">15242647</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Deveraux</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Ustrell</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Pickart</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Rechsteiner</surname>
            <given-names>M</given-names>
          </name>
          <article-title>A 26 S protease subunit that binds ubiquitin conjugates</article-title>
          <source>J Biol Chem</source>
          <year>1994</year>
          <volume>269</volume>
          <fpage>7059</fpage>
          <lpage>7061</lpage>
          <pub-id pub-id-type="pmid">8125911</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Husnjak</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Elsasser</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Randles</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Shi</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Hofmann</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Walters</surname>
            <given-names>KJ</given-names>
          </name>
          <name>
            <surname>Finley</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Dikic</surname>
            <given-names>I</given-names>
          </name>
          <article-title>Proteasome subunit Rpn13 is a novel ubiquitin receptor</article-title>
          <source>Nature</source>
          <year>2008</year>
          <volume>453</volume>
          <fpage>481</fpage>
          <lpage>488</lpage>
          <pub-id pub-id-type="doi">10.1038/nature06926</pub-id>
          <pub-id pub-id-type="pmid">18497817</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Elsasser</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Finley</surname>
            <given-names>D</given-names>
          </name>
          <article-title>Delivery of ubiquitinated substrates to protein-unfolding machines</article-title>
          <source>Nat Cell Biol</source>
          <year>2005</year>
          <volume>7</volume>
          <fpage>742</fpage>
          <lpage>749</lpage>
          <pub-id pub-id-type="doi">10.1038/ncb0805-742</pub-id>
          <pub-id pub-id-type="pmid">16056265</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Braun</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Matuschewski</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Rape</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Thoms</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Jentsch</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Role of the ubiquitin-selective CDC48(UFD1/NPL4)chaperone (segregase) in ERAD of OLE1 and other substrates</article-title>
          <source>Embo J</source>
          <year>2002</year>
          <volume>21</volume>
          <fpage>615</fpage>
          <lpage>621</lpage>
          <pub-id pub-id-type="doi">10.1093/emboj/21.4.615</pub-id>
          <pub-id pub-id-type="pmid">11847109</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Rape</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hoppe</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Gorr</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Kalocay</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Richly</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Jentsch</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Mobilization of processed, membrane-tethered SPT23 transcription factor by CDC48(UFD1/NPL4), a ubiquitin-selective chaperone</article-title>
          <source>Cell</source>
          <year>2001</year>
          <volume>107</volume>
          <fpage>667</fpage>
          <lpage>677</lpage>
          <pub-id pub-id-type="doi">10.1016/S0092-8674(01)00595-5</pub-id>
          <pub-id pub-id-type="pmid">11733065</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Rouiller</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>DeLaBarre</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>May</surname>
            <given-names>AP</given-names>
          </name>
          <name>
            <surname>Weis</surname>
            <given-names>WI</given-names>
          </name>
          <name>
            <surname>Brunger</surname>
            <given-names>AT</given-names>
          </name>
          <name>
            <surname>Milligan</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Wilson-Kubalek</surname>
            <given-names>EM</given-names>
          </name>
          <article-title>Conformational changes of the multifunction p97 AAA ATPase during its ATPase cycle</article-title>
          <source>Nat Struct Biol</source>
          <year>2002</year>
          <volume>9</volume>
          <fpage>950</fpage>
          <lpage>957</lpage>
          <pub-id pub-id-type="doi">10.1038/nsb872</pub-id>
          <pub-id pub-id-type="pmid">12434150</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bar-Nun</surname>
            <given-names>S</given-names>
          </name>
          <article-title>The role of p97/Cdc48p in endoplasmic reticulum-associated degradation: from the immune system to yeast</article-title>
          <source>Curr Top Microbiol Immunol</source>
          <year>2005</year>
          <volume>300</volume>
          <fpage>95</fpage>
          <lpage>125</lpage>
          <pub-id pub-id-type="doi">10.1007/3-540-28007-3_5</pub-id>
          <pub-id pub-id-type="pmid">16573238</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Shcherbik</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Haines</surname>
            <given-names>DS</given-names>
          </name>
          <article-title>Cdc48p(Npl4p/Ufd1p) binds and segregates membrane-anchored/tethered complexes via a polyubiquitin signal present on the anchors</article-title>
          <source>Mol Cell</source>
          <year>2007</year>
          <volume>25</volume>
          <fpage>385</fpage>
          <lpage>397</lpage>
          <pub-id pub-id-type="doi">10.1016/j.molcel.2007.01.024</pub-id>
          <pub-id pub-id-type="pmid">17289586</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Meyer</surname>
            <given-names>HH</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Warren</surname>
            <given-names>G</given-names>
          </name>
          <article-title>Direct binding of ubiquitin conjugates by the mammalian p97 adaptor complexes, p47 and Ufd1-Npl4</article-title>
          <source>Embo J</source>
          <year>2002</year>
          <volume>21</volume>
          <fpage>5645</fpage>
          <lpage>5652</lpage>
          <pub-id pub-id-type="doi">10.1093/emboj/cdf579</pub-id>
          <pub-id pub-id-type="pmid">12411482</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Ye</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Meyer</surname>
            <given-names>HH</given-names>
          </name>
          <name>
            <surname>Rapoport</surname>
            <given-names>TA</given-names>
          </name>
          <article-title>Function of the p97-Ufd1-Npl4 complex in retrotranslocation from the ER to the cytosol: dual recognition of nonubiquitinated polypeptide segments and polyubiquitin chains</article-title>
          <source>J Cell Biol</source>
          <year>2003</year>
          <volume>162</volume>
          <fpage>71</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="doi">10.1083/jcb.200302169</pub-id>
          <pub-id pub-id-type="pmid">12847084</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Schuberth</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Buchberger</surname>
            <given-names>A</given-names>
          </name>
          <article-title>UBX domain proteins: major regulators of the AAA ATPase Cdc48/p97</article-title>
          <source>Cell Mol Life Sci</source>
          <year>2008</year>
          <volume>65</volume>
          <fpage>2360</fpage>
          <lpage>2371</lpage>
          <pub-id pub-id-type="doi">10.1007/s00018-008-8072-8</pub-id>
          <pub-id pub-id-type="pmid">18438607</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hurley</surname>
            <given-names>JH</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Prag</surname>
            <given-names>G</given-names>
          </name>
          <article-title>Ubiquitin-binding domains</article-title>
          <source>Biochem J</source>
          <year>2006</year>
          <volume>399</volume>
          <fpage>361</fpage>
          <lpage>372</lpage>
          <pub-id pub-id-type="doi">10.1042/BJ20061138</pub-id>
          <pub-id pub-id-type="pmid">17034365</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Alexandru</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Graumann</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>GT</given-names>
          </name>
          <name>
            <surname>Kolawa</surname>
            <given-names>NJ</given-names>
          </name>
          <name>
            <surname>Fang</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Deshaies</surname>
            <given-names>RJ</given-names>
          </name>
          <article-title>UBXD7 binds multiple ubiquitin ligases and implicates p97 in HIF1alpha turnover</article-title>
          <source>Cell</source>
          <year>2008</year>
          <volume>134</volume>
          <fpage>804</fpage>
          <lpage>816</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2008.06.048</pub-id>
          <pub-id pub-id-type="pmid">18775313</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Pan</surname>
            <given-names>ZQ</given-names>
          </name>
          <name>
            <surname>Kentsis</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Dias</surname>
            <given-names>DC</given-names>
          </name>
          <name>
            <surname>Yamoah</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Nedd8 on cullin: building an expressway to protein destruction</article-title>
          <source>Oncogene</source>
          <year>2004</year>
          <volume>23</volume>
          <fpage>1985</fpage>
          <lpage>1997</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.onc.1207414</pub-id>
          <pub-id pub-id-type="pmid">15021886</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kurz</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Chou</surname>
            <given-names>YC</given-names>
          </name>
          <name>
            <surname>Willems</surname>
            <given-names>AR</given-names>
          </name>
          <name>
            <surname>Meyer-Schaller</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Hecht</surname>
            <given-names>ML</given-names>
          </name>
          <name>
            <surname>Tyers</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Peter</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Sicheri</surname>
            <given-names>F</given-names>
          </name>
          <article-title>Dcn1 functions as a scaffold-type E3 ligase for cullin neddylation</article-title>
          <source>Mol Cell</source>
          <year>2008</year>
          <volume>29</volume>
          <fpage>23</fpage>
          <lpage>35</lpage>
          <pub-id pub-id-type="doi">10.1016/j.molcel.2007.12.012</pub-id>
          <pub-id pub-id-type="pmid">18206966</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kurz</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ozlu</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Rudolf</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>O'Rourke</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Luke</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Hofmann</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Hyman</surname>
            <given-names>AA</given-names>
          </name>
          <name>
            <surname>Bowerman</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Peter</surname>
            <given-names>M</given-names>
          </name>
          <article-title>The conserved protein DCN-1/Dcn1p is required for cullin neddylation in C. elegans and S. cerevisiae</article-title>
          <source>Nature</source>
          <year>2005</year>
          <volume>435</volume>
          <fpage>1257</fpage>
          <lpage>1261</lpage>
          <pub-id pub-id-type="doi">10.1038/nature03662</pub-id>
          <pub-id pub-id-type="pmid">15988528</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Scott</surname>
            <given-names>DC</given-names>
          </name>
          <name>
            <surname>Monda</surname>
            <given-names>JK</given-names>
          </name>
          <name>
            <surname>Grace</surname>
            <given-names>CR</given-names>
          </name>
          <name>
            <surname>Duda</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Kriwacki</surname>
            <given-names>RW</given-names>
          </name>
          <name>
            <surname>Kurz</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Schulman</surname>
            <given-names>BA</given-names>
          </name>
          <article-title>A dual E3 mechanism for Rub1 ligation to Cdc53</article-title>
          <source>Mol Cell</source>
          <year>2010</year>
          <volume>39</volume>
          <fpage>784</fpage>
          <lpage>796</lpage>
          <pub-id pub-id-type="doi">10.1016/j.molcel.2010.08.030</pub-id>
          <pub-id pub-id-type="pmid">20832729</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kamura</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Conrad</surname>
            <given-names>MN</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Conaway</surname>
            <given-names>RC</given-names>
          </name>
          <name>
            <surname>Conaway</surname>
            <given-names>JW</given-names>
          </name>
          <article-title>The Rbx1 subunit of SCF and VHL E3 ubiquitin ligase activates Rub1 modification of cullins Cdc53 and Cul2</article-title>
          <source>Genes Dev</source>
          <year>1999</year>
          <volume>13</volume>
          <fpage>2928</fpage>
          <lpage>2933</lpage>
          <pub-id pub-id-type="doi">10.1101/gad.13.22.2928</pub-id>
          <pub-id pub-id-type="pmid">10579999</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Megumi</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Miyauchi</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Sakurai</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Nobeyama</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Lorick</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Nakamura</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Chiba</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Tanaka</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Weissman</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Kirisako</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ogawa</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Iwai</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Multiple roles of Rbx1 in the VBC-Cul2 ubiquitin ligase complex</article-title>
          <source>Genes Cells</source>
          <year>2005</year>
          <volume>10</volume>
          <fpage>679</fpage>
          <lpage>691</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-2443.2005.00869.x</pub-id>
          <pub-id pub-id-type="pmid">15966899</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Morimoto</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Nishida</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Nagayama</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Yasuda</surname>
            <given-names>H</given-names>
          </name>
          <article-title>Nedd8-modification of Cul1 is promoted by Roc1 as a Nedd8-E3 ligase and regulates its stability</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>2003</year>
          <volume>301</volume>
          <fpage>392</fpage>
          <lpage>398</lpage>
          <pub-id pub-id-type="doi">10.1016/S0006-291X(02)03051-6</pub-id>
          <pub-id pub-id-type="pmid">12565873</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Petroski</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Deshaies</surname>
            <given-names>RJ</given-names>
          </name>
          <article-title>Function and regulation of cullin-RING ubiquitin ligases</article-title>
          <source>Nat Rev Mol Cell Biol</source>
          <year>2005</year>
          <volume>6</volume>
          <fpage>9</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="pmid">15688063</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Duda</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Borg</surname>
            <given-names>LA</given-names>
          </name>
          <name>
            <surname>Scott</surname>
            <given-names>DC</given-names>
          </name>
          <name>
            <surname>Hunt</surname>
            <given-names>HW</given-names>
          </name>
          <name>
            <surname>Hammel</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Schulman</surname>
            <given-names>BA</given-names>
          </name>
          <article-title>Structural insights into NEDD8 activation of cullin-RING ligases: conformational control of conjugation</article-title>
          <source>Cell</source>
          <year>2008</year>
          <volume>134</volume>
          <fpage>995</fpage>
          <lpage>1006</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2008.07.022</pub-id>
          <pub-id pub-id-type="pmid">18805092</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Saha</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Deshaies</surname>
            <given-names>RJ</given-names>
          </name>
          <article-title>Multimodal activation of the ubiquitin ligase SCF by Nedd8 conjugation</article-title>
          <source>Mol Cell</source>
          <year>2008</year>
          <volume>32</volume>
          <fpage>21</fpage>
          <lpage>31</lpage>
          <pub-id pub-id-type="doi">10.1016/j.molcel.2008.08.021</pub-id>
          <pub-id pub-id-type="pmid">18851830</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Wenger</surname>
            <given-names>RH</given-names>
          </name>
          <name>
            <surname>Stiehl</surname>
            <given-names>DP</given-names>
          </name>
          <name>
            <surname>Camenisch</surname>
            <given-names>G</given-names>
          </name>
          <article-title>Integration of oxygen signaling at the consensus HRE</article-title>
          <source>Sci STKE</source>
          <year>2005</year>
          <volume>2005</volume>
          <fpage>re12</fpage>
          <pub-id pub-id-type="doi">10.1126/stke.3062005re12</pub-id>
          <pub-id pub-id-type="pmid">16234508</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Ivan</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kaelin</surname>
            <given-names>WG</given-names>
            <suffix>Jr</suffix>
          </name>
          <article-title>The von Hippel-Lindau tumor suppressor protein</article-title>
          <source>Curr Opin Genet Dev</source>
          <year>2001</year>
          <volume>11</volume>
          <fpage>27</fpage>
          <lpage>34</lpage>
          <pub-id pub-id-type="doi">10.1016/S0959-437X(00)00152-0</pub-id>
          <pub-id pub-id-type="pmid">11163147</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B28">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Salvat</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Acquaviva</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Scheffner</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Robbins</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Piechaczyk</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Jariel-Encontre</surname>
            <given-names>I</given-names>
          </name>
          <article-title>Molecular characterization of the thermosensitive E1 ubiquitin-activating enzyme cell mutant A31N-ts20. Requirements upon different levels of E1 for the ubiquitination/degradation of the various protein substrates in vivo</article-title>
          <source>Eur J Biochem</source>
          <year>2000</year>
          <volume>267</volume>
          <fpage>3712</fpage>
          <lpage>3722</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1432-1327.2000.01404.x</pub-id>
          <pub-id pub-id-type="pmid">10848989</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B29">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Brownell</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Sintchak</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Gavin</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Liao</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Bruzzese</surname>
            <given-names>FJ</given-names>
          </name>
          <name>
            <surname>Bump</surname>
            <given-names>NJ</given-names>
          </name>
          <name>
            <surname>Soucy</surname>
            <given-names>TA</given-names>
          </name>
          <name>
            <surname>Milhollen</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Burkhardt</surname>
            <given-names>AL</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Loke</surname>
            <given-names>HK</given-names>
          </name>
          <name>
            <surname>Lingaraj</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Hamman</surname>
            <given-names>KB</given-names>
          </name>
          <name>
            <surname>Spelman</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Cullis</surname>
            <given-names>CA</given-names>
          </name>
          <name>
            <surname>Langston</surname>
            <given-names>SP</given-names>
          </name>
          <name>
            <surname>Vyskocil</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Sells</surname>
            <given-names>TB</given-names>
          </name>
          <name>
            <surname>Mallender</surname>
            <given-names>WD</given-names>
          </name>
          <name>
            <surname>Visiers</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Claiborne</surname>
            <given-names>CF</given-names>
          </name>
          <name>
            <surname>Rolfe</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bolen</surname>
            <given-names>JB</given-names>
          </name>
          <name>
            <surname>Dick</surname>
            <given-names>LR</given-names>
          </name>
          <article-title>Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situ</article-title>
          <source>Mol Cell</source>
          <year>2010</year>
          <volume>37</volume>
          <fpage>102</fpage>
          <lpage>111</lpage>
          <pub-id pub-id-type="doi">10.1016/j.molcel.2009.12.024</pub-id>
          <pub-id pub-id-type="pmid">20129059</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B30">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Wada</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Yeh</surname>
            <given-names>ET</given-names>
          </name>
          <name>
            <surname>Kamitani</surname>
            <given-names>T</given-names>
          </name>
          <article-title>Identification of NEDD8-conjugation site in human cullin-2</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>1999</year>
          <volume>257</volume>
          <fpage>100</fpage>
          <lpage>105</lpage>
          <pub-id pub-id-type="doi">10.1006/bbrc.1999.0339</pub-id>
          <pub-id pub-id-type="pmid">10092517</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B31">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bilodeau</surname>
            <given-names>PS</given-names>
          </name>
          <name>
            <surname>Urbanowski</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Winistorfer</surname>
            <given-names>SC</given-names>
          </name>
          <name>
            <surname>Piper</surname>
            <given-names>RC</given-names>
          </name>
          <article-title>The Vps27p Hse1p complex binds ubiquitin and mediates endosomal protein sorting</article-title>
          <source>Nat Cell Biol</source>
          <year>2002</year>
          <volume>4</volume>
          <fpage>534</fpage>
          <lpage>539</lpage>
          <pub-id pub-id-type="pmid">12055639</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B32">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hirano</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kawasaki</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ura</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Kato</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Raiborg</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Stenmark</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Wakatsuki</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Double-sided ubiquitin binding of Hrs-UIM in endosomal protein sorting</article-title>
          <source>Nat Struct Mol Biol</source>
          <year>2006</year>
          <volume>13</volume>
          <fpage>272</fpage>
          <lpage>277</lpage>
          <pub-id pub-id-type="doi">10.1038/nsmb1051</pub-id>
          <pub-id pub-id-type="pmid">16462748</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B33">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Wu</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Pan</surname>
            <given-names>ZQ</given-names>
          </name>
          <article-title>Conjugation of Nedd8 to CUL1 enhances the ability of the ROC1-CUL1 complex to promote ubiquitin polymerization</article-title>
          <source>J Biol Chem</source>
          <year>2000</year>
          <volume>275</volume>
          <fpage>32317</fpage>
          <lpage>32324</lpage>
          <pub-id pub-id-type="pmid">10921923</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B34">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kim</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Tannenbaum</surname>
            <given-names>SR</given-names>
          </name>
          <name>
            <surname>White</surname>
            <given-names>FM</given-names>
          </name>
          <article-title>Global phosphoproteome of HT-29 human colon adenocarcinoma cells</article-title>
          <source>J Proteome Res</source>
          <year>2005</year>
          <volume>4</volume>
          <fpage>1339</fpage>
          <lpage>1346</lpage>
          <pub-id pub-id-type="doi">10.1021/pr050048h</pub-id>
          <pub-id pub-id-type="pmid">16083285</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B35">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Imami</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Sugiyama</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Kyono</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Tomita</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ishihama</surname>
            <given-names>Y</given-names>
          </name>
          <article-title>Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column</article-title>
          <source>Anal Sci</source>
          <year>2008</year>
          <volume>24</volume>
          <fpage>161</fpage>
          <lpage>166</lpage>
          <pub-id pub-id-type="doi">10.2116/analsci.24.161</pub-id>
          <pub-id pub-id-type="pmid">18187866</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B36">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Katiyar</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Lennarz</surname>
            <given-names>WJ</given-names>
          </name>
          <article-title>Studies on the intracellular localization of hHR23B</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>2005</year>
          <volume>337</volume>
          <fpage>1296</fpage>
          <lpage>1300</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbrc.2005.09.192</pub-id>
          <pub-id pub-id-type="pmid">16253613</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B37">
        <mixed-citation publication-type="journal">
          <name>
            <surname>van der Spek</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Eker</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Rademakers</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Visser</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Sugasawa</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Masutani</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Hanaoka</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Bootsma</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Hoeijmakers</surname>
            <given-names>JH</given-names>
          </name>
          <article-title>XPC and human homologs of RAD23: intracellular localization and relationship to other nucleotide excision repair complexes</article-title>
          <source>Nucleic Acids Res</source>
          <year>1996</year>
          <volume>24</volume>
          <fpage>2551</fpage>
          <lpage>2559</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/24.13.2551</pub-id>
          <pub-id pub-id-type="pmid">8692695</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B38">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Buchberger</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Howard</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Proctor</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bycroft</surname>
            <given-names>M</given-names>
          </name>
          <article-title>The UBX domain: a widespread ubiquitin-like module</article-title>
          <source>J Mol Biol</source>
          <year>2001</year>
          <volume>307</volume>
          <fpage>17</fpage>
          <lpage>24</lpage>
          <pub-id pub-id-type="doi">10.1006/jmbi.2000.4462</pub-id>
          <pub-id pub-id-type="pmid">11243799</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B39">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hicke</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Schubert</surname>
            <given-names>HL</given-names>
          </name>
          <name>
            <surname>Hill</surname>
            <given-names>CP</given-names>
          </name>
          <article-title>Ubiquitin-binding domains</article-title>
          <source>Nat Rev Mol Cell Biol</source>
          <year>2005</year>
          <volume>6</volume>
          <fpage>610</fpage>
          <lpage>621</lpage>
          <pub-id pub-id-type="doi">10.1038/nrm1701</pub-id>
          <pub-id pub-id-type="pmid">16064137</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B40">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Ohno</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Jee</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Fujiwara</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Tenno</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Goda</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Tochio</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Kobayashi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Hiroaki</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Shirakawa</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Structure of the UBA domain of Dsk2p in complex with ubiquitin molecular determinants for ubiquitin recognition</article-title>
          <source>Structure</source>
          <year>2005</year>
          <volume>13</volume>
          <fpage>521</fpage>
          <lpage>532</lpage>
          <pub-id pub-id-type="doi">10.1016/j.str.2005.01.011</pub-id>
          <pub-id pub-id-type="pmid">15837191</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B41">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Swanson</surname>
            <given-names>KA</given-names>
          </name>
          <name>
            <surname>Kang</surname>
            <given-names>RS</given-names>
          </name>
          <name>
            <surname>Stamenova</surname>
            <given-names>SD</given-names>
          </name>
          <name>
            <surname>Hicke</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Radhakrishnan</surname>
            <given-names>I</given-names>
          </name>
          <article-title>Solution structure of Vps27 UIM-ubiquitin complex important for endosomal sorting and receptor downregulation</article-title>
          <source>EMBO J</source>
          <year>2003</year>
          <volume>22</volume>
          <fpage>4597</fpage>
          <lpage>4606</lpage>
          <pub-id pub-id-type="doi">10.1093/emboj/cdg471</pub-id>
          <pub-id pub-id-type="pmid">12970172</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B42">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Whitby</surname>
            <given-names>FG</given-names>
          </name>
          <name>
            <surname>Xia</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Pickart</surname>
            <given-names>CM</given-names>
          </name>
          <name>
            <surname>Hill</surname>
            <given-names>CP</given-names>
          </name>
          <article-title>Crystal structure of the human ubiquitin-like protein NEDD8 and interactions with ubiquitin pathway enzymes</article-title>
          <source>J Biol Chem</source>
          <year>1998</year>
          <volume>273</volume>
          <fpage>34983</fpage>
          <lpage>34991</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.273.52.34983</pub-id>
          <pub-id pub-id-type="pmid">9857030</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B43">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Oved</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Mosesson</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zwang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Santonico</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Shtiegman</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Marmor</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Kochupurakkal</surname>
            <given-names>BS</given-names>
          </name>
          <name>
            <surname>Katz</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Lavi</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Cesareni</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Yarden</surname>
            <given-names>Y</given-names>
          </name>
          <article-title>Conjugation to Nedd8 instigates ubiquitylation and down-regulation of activated receptor tyrosine kinases</article-title>
          <source>J Biol Chem</source>
          <year>2006</year>
          <volume>281</volume>
          <fpage>21640</fpage>
          <lpage>21651</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M513034200</pub-id>
          <pub-id pub-id-type="pmid">16735510</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B44">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Tanaka</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kawashima</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Yeh</surname>
            <given-names>ET</given-names>
          </name>
          <name>
            <surname>Kamitani</surname>
            <given-names>T</given-names>
          </name>
          <article-title>Regulation of the NEDD8 conjugation system by a splicing variant, NUB1L</article-title>
          <source>J Biol Chem</source>
          <year>2003</year>
          <volume>278</volume>
          <fpage>32905</fpage>
          <lpage>32913</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M212057200</pub-id>
          <pub-id pub-id-type="pmid">12816948</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B45">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Su</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Lau</surname>
            <given-names>AF</given-names>
          </name>
          <article-title>Ubiquitin-like and ubiquitin-associated domain proteins: significance in proteasomal degradation</article-title>
          <source>Cell Mol Life Sci</source>
          <year>2009</year>
          <volume>66</volume>
          <fpage>2819</fpage>
          <lpage>2833</lpage>
          <pub-id pub-id-type="doi">10.1007/s00018-009-0048-9</pub-id>
          <pub-id pub-id-type="pmid">19468686</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B46">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Wang</surname>
            <given-names>GL</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>BH</given-names>
          </name>
          <name>
            <surname>Rue</surname>
            <given-names>EA</given-names>
          </name>
          <name>
            <surname>Semenza</surname>
            <given-names>GL</given-names>
          </name>
          <article-title>Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1995</year>
          <volume>92</volume>
          <fpage>5510</fpage>
          <lpage>5514</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.92.12.5510</pub-id>
          <pub-id pub-id-type="pmid">7539918</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B47">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Gradin</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>McGuire</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wenger</surname>
            <given-names>RH</given-names>
          </name>
          <name>
            <surname>Kvietikova</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Whitelaw</surname>
            <given-names>ML</given-names>
          </name>
          <name>
            <surname>Toftgard</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Tora</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Gassmann</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Poellinger</surname>
            <given-names>L</given-names>
          </name>
          <article-title>Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the Arnt transcription factor</article-title>
          <source>Mol Cell Biol</source>
          <year>1996</year>
          <volume>16</volume>
          <fpage>5221</fpage>
          <lpage>5231</lpage>
          <pub-id pub-id-type="pmid">8816435</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B48">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Jiang</surname>
            <given-names>BH</given-names>
          </name>
          <name>
            <surname>Rue</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>GL</given-names>
          </name>
          <name>
            <surname>Roe</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Semenza</surname>
            <given-names>GL</given-names>
          </name>
          <article-title>Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1</article-title>
          <source>J Biol Chem</source>
          <year>1996</year>
          <volume>271</volume>
          <fpage>17771</fpage>
          <lpage>17778</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.271.30.17771</pub-id>
          <pub-id pub-id-type="pmid">8663540</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B49">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Stroka</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Burkhardt</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Desbaillets</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Wenger</surname>
            <given-names>RH</given-names>
          </name>
          <name>
            <surname>Neil</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Bauer</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Gassmann</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Candinas</surname>
            <given-names>D</given-names>
          </name>
          <article-title>HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia</article-title>
          <source>FASEB J</source>
          <year>2001</year>
          <volume>15</volume>
          <fpage>2445</fpage>
          <lpage>2453</lpage>
          <pub-id pub-id-type="pmid">11689469</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B50">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Talks</surname>
            <given-names>KL</given-names>
          </name>
          <name>
            <surname>Turley</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Gatter</surname>
            <given-names>KC</given-names>
          </name>
          <name>
            <surname>Maxwell</surname>
            <given-names>PH</given-names>
          </name>
          <name>
            <surname>Pugh</surname>
            <given-names>CW</given-names>
          </name>
          <name>
            <surname>Ratcliffe</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Harris</surname>
            <given-names>AL</given-names>
          </name>
          <article-title>The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages</article-title>
          <source>Am J Pathol</source>
          <year>2000</year>
          <volume>157</volume>
          <fpage>411</fpage>
          <lpage>421</lpage>
          <pub-id pub-id-type="doi">10.1016/S0002-9440(10)64554-3</pub-id>
          <pub-id pub-id-type="pmid">10934146</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B51">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Zhong</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>De Marzo</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Laughner</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Lim</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hilton</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Zagzag</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Buechler</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Isaacs</surname>
            <given-names>WB</given-names>
          </name>
          <name>
            <surname>Semenza</surname>
            <given-names>GL</given-names>
          </name>
          <name>
            <surname>Simons</surname>
            <given-names>JW</given-names>
          </name>
          <article-title>Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases</article-title>
          <source>Cancer Res</source>
          <year>1999</year>
          <volume>59</volume>
          <fpage>5830</fpage>
          <lpage>5835</lpage>
          <pub-id pub-id-type="pmid">10582706</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B52">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Groulx</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Oxygen-dependent ubiquitination and degradation of hypoxia-inducible factor requires nuclear-cytoplasmic trafficking of the von Hippel-Lindau tumor suppressor protein</article-title>
          <source>Mol Cell Biol</source>
          <year>2002</year>
          <volume>22</volume>
          <fpage>5319</fpage>
          <lpage>5336</lpage>
          <pub-id pub-id-type="doi">10.1128/MCB.22.15.5319-5336.2002</pub-id>
          <pub-id pub-id-type="pmid">12101228</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B53">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Soucy</surname>
            <given-names>TA</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>PG</given-names>
          </name>
          <name>
            <surname>Milhollen</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Berger</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Gavin</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Adhikari</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Brownell</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Burke</surname>
            <given-names>KE</given-names>
          </name>
          <name>
            <surname>Cardin</surname>
            <given-names>DP</given-names>
          </name>
          <name>
            <surname>Critchley</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Cullis</surname>
            <given-names>CA</given-names>
          </name>
          <name>
            <surname>Doucette</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Garnsey</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Gaulin</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Gershman</surname>
            <given-names>RE</given-names>
          </name>
          <name>
            <surname>Lublinsky</surname>
            <given-names>AR</given-names>
          </name>
          <name>
            <surname>McDonald</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Mizutani</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Narayanan</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Olhava</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Peluso</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Rezaei</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Sintchak</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Talreja</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Thomas</surname>
            <given-names>MP</given-names>
          </name>
          <name>
            <surname>Traore</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Vyskocil</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Weatherhead</surname>
            <given-names>GS</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Dick</surname>
            <given-names>LR</given-names>
          </name>
          <name>
            <surname>Claiborne</surname>
            <given-names>CF</given-names>
          </name>
          <name>
            <surname>Rolfe</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bolen</surname>
            <given-names>JB</given-names>
          </name>
          <name>
            <surname>Langston</surname>
            <given-names>SP</given-names>
          </name>
          <article-title>An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer</article-title>
          <source>Nature</source>
          <year>2009</year>
          <volume>458</volume>
          <fpage>732</fpage>
          <lpage>736</lpage>
          <pub-id pub-id-type="doi">10.1038/nature07884</pub-id>
          <pub-id pub-id-type="pmid">19360080</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>